Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full ...
1 Day PHAR -2.65% DJIA -0.10% Russell 2K 0.52% Health Care/Life Sciences 0.33% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback